Literature DB >> 3928811

Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.

A J Azzaro, J King, J Kotzuk, D D Schoepp, J Frost, S Schochet.   

Abstract

The kinetic properties of type A and type B monoamine oxidase (MAO) were examined in guinea pig striatum, rat striatum, and autopsied human caudate nucleus using 3,4-dihydroxyphenylethylamine (dopamine, DA) as the substrate. MAO isozyme ratio in guinea pig striatum (28% type A/72% type B) was similar to that in human caudate nucleus (25% type A/75% type B) but different from that in rat striatum (76% type A/24% type B). Additional similarities between guinea pig striatum and human caudate nucleus were demonstrated for the affinity constants (Km) of each MAO) isozyme toward DA. Endogenous concentrations of DA, 3-methoxytyramine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid were also measured in guinea pig and rat striatum following selective type A (clorgyline-treated) and type B (deprenyl-treated) MAO inhibition. In guinea pig, DA metabolism was equally but only partially affected by clorgyline or deprenyl alone. Combined treatment with clorgyline and deprenyl was required for maximal alterations in DA metabolism. By contrast, DA metabolism in rat striatum was extensively altered by clorgyline but unaffected by deprenyl alone. Finally, the deamination of DA in synaptosomes from guinea pig striatum was examined following selective MAO isozyme inhibition. Neither clorgyline nor deprenyl alone reduced synaptosomal DA deamination. However, clorgyline and deprenyl together reduced DA deamination by 94%. These results suggest that the isozyme localization and/or isozyme affinity for DA, rather than the absolute isozyme content, determines the relative importance of type A and type B MAO in synaptic DA deamination. Moreover, based on the enzyme kinetic properties of each MAO isozyme, guinea pig striatum may serve as a suitable model of human DA deamination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928811     DOI: 10.1111/j.1471-4159.1985.tb04086.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.

Authors:  A J Azzaro; J B Amedro; L M Brown; D J Smith; G M Williams
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

Review 2.  H2O2: a dynamic neuromodulator.

Authors:  Margaret E Rice
Journal:  Neuroscientist       Date:  2011-06-10       Impact factor: 7.519

3.  Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain.

Authors:  I A Paterson; B A Davis; D A Durden; A V Juorio; P H Yu; G Ivy; W Milgram; A Mendonca; P Wu; A A Boulton
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

4.  Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.

Authors:  T Ilani; I Lamensdorf; J P Finberg
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions.

Authors:  E Scarr; D M Wingerchuk; A V Juorio; I A Paterson
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

Review 6.  Classification of H₂O₂as a neuromodulator that regulates striatal dopamine release on a subsecond time scale.

Authors:  Jyoti C Patel; Margaret E Rice
Journal:  ACS Chem Neurosci       Date:  2012-11-08       Impact factor: 4.418

7.  Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling.

Authors:  Li Bao; Marat V Avshalumov; Jyoti C Patel; Christian R Lee; Evan W Miller; Christopher J Chang; Margaret E Rice
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

8.  Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.

Authors:  M K Lakshmana; B S Rao; N K Dhingra; R Ravikumar; S Sudha; B L Meti; T R Raju
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

9.  Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.

Authors:  P T Männistö; P Tuomainen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

10.  Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.

Authors:  P Blier; C Bouchard
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.